Abstract
Azole antifungal drugs target CYP51A in Aspergillus fumigatus by binding with the active site of the protein, blocking ergosterol biosynthesis. Resistance to azole antifungal drugs is now common, with a leucine to histidine amino acid substitution at position 98 the most frequent, predominantly conferring resistance to itraconazole, although cross-resistance has been reported in conjunction with other mutations. In this study, we create a homology model of CYP51A using a recently published crystal structure of the paralog protein CYP51B. The derived structures, wild type, and L98H mutant are positioned within a lipid membrane bilayer and subjected to molecular dynamics simulations in order improve the accuracy of both models. The structural analysis from our simulations suggests a decrease in active site surface from the formation of hydrogen bonds between the histidine substitution and neighboring polar side chains, potentially preventing the binding of azole drugs. This study yields a biologically relevant structure and set of dynamics of the A. fumigatus Lanosterol 14 alpha-demethylase enzyme and provides further insight into azole antifungal drug resistance.
Keywords: Aspergillus fumigatus, CYP51A, aspergillosis, lipid bilayer, 14α-lanosterol demethylase
Introduction
Aspergillus fumigatus is the causative agent of invasive aspergillosis (IA), a life-threatening infection in immune compromised individuals. Orally administered azole antifungals1 are the first-line drugs for the treatment of IA in humans in the UK, however, resistance to these drugs is rising with resistance ranging from 0 to 6.5%.2 Azole-resistant A. fumigatus strains have been identified across the globe,3,4,5,6,7 with itraconazole resistance the most common, and resistance to voriconazole increasing, presenting an evolving problem for public health.8,9 Cross-resistance has also been reported in conjunction with other mutations.10
Mutations in the target gene of azole anti-fungal drugs, cyp51a, have been shown to confer resistance phenotypes in A. fumigatus11,12,13cyp51a encodes a CYP450-dependent enzyme, 14α-lanosterol demethylase, which is inhibited when azole drugs bind to the catalytic iron of the heme prosthetic group in the CYP51A active site. An amino acid change from leucine to histidine at position 98 of cyp51a coupled with a tandem repetition in the gene promoter is the most common resistance mechanism,14 conferring resistance to the first-line antifungal drug itraconazole.
Structural and biochemical characterization of fungal CYP51 is difficult due to being an embedded membrane protein. Previous studies have used crystal structures of Mycobacterium tuberculosis CYP5115 (MT-CYP51)16,17 and nonfungal eukaryotic species,18 with low sequence similarity to fungal CYP51.19 Bacterial CYP51 proteins are also soluble, whereas fungal CYP51 is an integrated membrane protein.
Snelders et al.20 improved the homology model by using the crystal structure of the human lanosterol 14α-demethylase (PDB code: 3I3K), conferring 38% sequence identity. Although Snelders et al. acknowledge the presence of the heme prosthetic cofactor in CYP51A, there is no description of heme in their molecular dynamics (MD) simulations. Therefore, the results presented in Alcazar-Fuoli et al. and Snelders et al. do not represent the true extent of the biological problem.
The A. fumigatus protein CYP51B (AfCYP51B) has 59% amino similarity with its paralog, CYP51A (AfCYP51A), with the X-ray crystal structure for AfCYP51B published in 2015.21 It is thought that AfCYP51B is expressed constitutively and is involved in growth rate and fungal cell maintenance,22 while AfCYP51A expression is induced by the presence of azole drugs. Clinical studies have suggested AfCYP51B is a redundant gene whose expression becomes important when AfCYP51A is absent.23,24 A recent homology study by Lie et al.18 yielded stability measurements of three azole drugs interacting within an implicit solvated buried active site of AfCYP51A. A set of model homologs that demonstrated superior coverage quality was subjected to an energy minimization step. Minimized structures, more often than not, represent an energy local minimum, while sufficient exploration of phase-space in pursuit of a more biological comparable structure requires extensive time-integration. A crystallographic study on cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer.25 The previous computational studies had excluded the complex micro-environment of AfCYP51A, notably, the N-terminal anchored across a lipid membrane bilayer.
We employ an all-atom representation of AfCYP51A using the crystal structure of AfCYP51B as the homology model template. From this structure, an L98H single point mutant variant can be created. The transmembrane (TM) domain was identified and the integral TM domain α-helix was embedded in a model 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) membrane bilayer. The inclusion of a Fe2+ dummy model provides the simulation dynamic exchange between the metal and its immediate environment and is a significant improvement over earlier models of covalently bound metal models.26 The cationic dummy atom approach describes a metal center coordinated with a set of cationic dummy atoms. This approach not only captures correct electrostatic effects but it is also capable of dynamic ligand exchange with the environment and maintaining the correct number of ligand donors.27 MD simulations performed in this study further the biological relevance and understanding of azole antifungal drug resistance from the single amino acid mutation, L98H, far from the buried active site.28,29
Methods
Model generation
All raw reads and relevant information in this study have been submitted to the European Nucleotide Archive under project accession number PRJEB8623. Genomic DNA sequences for both the L98H mutant and wild type Afcyp51a were obtained from a previous study.11 A three-dimensional homology model, one for the wild type and another for the L98H mutant, was produced within Schrodinger Maestro (2015-4) using a BLAST homology search. The inclusion threshold was set to 0.005 and three iterations were applied. The first 36 residues from the N-terminal and last five residues before the C-terminal were not predicted by the BLAST homology search. The derived tertiary structure from the BLAST homology search also included the heme prosthetic group and Fe2+ metal ligand, coordinated to a proximal cysteine thiolate.
Simulation details
All-atom MD simulations were performed using the Gromacs simulation package, version 5.1.2.30 The integration time step was set to 2 fs, and the leapfrog algorithm was used for time-step integration. All bonded atoms were holonomically constrained using the LINCS constraint algorithm;31 the LINCS iteration and order was set to 1 and 12, respectively. The short-range neighbor interaction list cut-off was fixed to 1.2 nm and updated every 10 fs. Short-range interactions were modeled using a 12–6 Lennard-Jones potential and were truncated at 1.2 nm using the potential-shift cutoff modifier from 1.0 nm. Short-range electrostatic interactions were truncated at 1.2 nm and long-range electrostatics were calculated using the Particle Mesh Ewald scheme32 with dispersion correction applied to the energy and the pressure.
The temperature was coupled using the V-rescale scheme33 over two groups; the protein-complex, including the protein, heme prosthetic group and Fe2+ metal-ligand; and the solvent with counter ions, at a physiological value of 310 K. The pressure was maintained at one atmosphere by first applying a semi-isotropic Berendsen coupling34 before switching to the Parrinello-Rahman scheme,35 to increase the accuracy of the NPT (fixed number of particles, fixed pressure and fixed temperature) ensemble. Loose coupling was applied between the protein-complex and the water environment and the compressibility was set to 4.5e-5. Periodic boundary conditions were applied in three dimensions. Coordinates, velocities and energies were saved every 5 ps during production simulations.
A cubic periodic unit cell was employed and the solute was fully hydrated with Tip3p water solvent molecules. The distance of the solute to the unit cell boundary was adjusted to prevent periodic image artefacts. Calcium ions were added to yield a net neutral charge.
Model POPC bilayer construction
A united-atom POPC lipid representation was employed. POPC lipids are naturally present in eukaryotic cell membranes and parameters provided36 show reliable free energy estimates compatible with the Amber99SB force field.37 A three-dimensional structural representation of a single POPC lipid was replicated in the x-y plane to make a leaflet of 126 lipids. The structure was copied, flipped and displaced to align lipid tail ends, resulting in a 252-lipid bilayer. The system was fully solvated with Tip3P water molecules. Using the simulation details provided above, the structure was subjected to a steepest descent minimization with a maximum force tolerance of 1,000 kJ mol−1 nm−1. Then, a 1,000 kJ mol−1 position restraint was applied to the phosphate group of each lipid before subjecting the system to a 100 ps simulation using the NVT ensemble. The position restraint was removed, and a semi-isotropic Berendsen pressure coupling was added for a 1 ns simulation. Finally, the Berendsen coupling was replaced with the Parrinello-Rahman scheme and the system was left to equilibrate for 30 ns. Measurements of the average bilayer thickness and area per lipid indicated that the final structure was suitable for protein insertion.
Protein structural equilibration
The protein-complex was energy minimized in vacuum using steepest descent with a maximum force tolerance of 1,000 kJ mol−1 nm−1. The resolved structure was then fully hydrated with solvent molecules and necessary counter ions, before subjecting the complete system to a further energy minimization while applying position restraints on the protein-complex. The restraints were then removed from the protein, and the structure was minimized further. Finally, all restraints were removed and the system underwent a final steepest descent minimization.
The atomic-partial charges, bond force constants and bond equilibrium values for the heme prosthetic group were taken from.38 The nonbonded potentials, force constants, equilibrium values, and atomic-partial of the Fe2+ dummy atom were taken from Duarte et al.27 The nonbonded potentials were fitted to the Gromacs sigma and epsilon format using the method outlined in the supporting information of Liao et al.39 Observation of Fe2+ bond distances revealed bond distances beyond the equilibrium bond value. An MD simulation using the NVT ensemble, with the temperature set at 274 K and an integration step to the smaller value of 0.001 fs, was performed for 10 ps to rectify this discrepancy. Position restraints of 1,000 kJ mol−1 were then applied to both carbon atoms immediately bonded to the heme nitrogen atoms along with the central Fe2+ atom; the dummy atoms were left unrestrained. The integration step was set to 0.002 fs and a 50 ps NPT simulation using the Berendsen pressure-coupling was performed. The coordinates and velocities were preserved and the simulation was extended by a further 50 ps using the Parrinello-Rahman pressure coupling scheme.
Protein insertion
The identified TM domain was positioned across the hydrophobic region of the lipid bilayer. The intracellular N-terminal sequence was positioned within the phosphate head group and those lipids that overlapped protein residues were removed. A set of 1,000 kJ mol−1 position restraints was then applied to the protein, heme prosthetic group and dummy iron and the system was subjected to a steepest descent minimization. The restraints were maintained and a 50 ps simulation using the NVT ensemble was performed to initiate the packing of lipids around the protein. The bilayer-protein complex was then fully solvated using Tip3P molecules and neutralized using counter-ions. Water molecules that had been randomly placed within the lipid alkyl tail region were removed.
Results
A BLAST sequence search was performed using globally conserved residues matching the cytochrome P450 family revealed and 221 homologs, from which the top-scoring crystal structure, sterol 14-α demethylase (AfCYP51B), from the pathogenic filamentous fungus A. fumigatus in complex with the small molecule (R)-N-(1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl)-4-(5-phenyl- 1,3,4-oxadi-azol-2-yl)benzamide-17 (4UYL), yielded an identity of 65%. Alignment was performed using Clustal W40 and the secondary structure and loop structures were calculated using Prime.41 The heme prosthetic group and Fe2+ ligand were included.
The homology search yielded an N- and C-terminal truncated three-dimensional structure. To reconstruct the two missing sequences, a structural prediction calculation was performed over both sequences using I-TASSER. This is a free protein-fold predictor service that is consistently grouped among the most accurate protein prediction services available.42 The prediction of the wild type and L98H mutant protein structure yielded identical confidence and TM-scores, 1.44 and 0.91 ± 0.06, respectively. The confidence intervals spans [−5, 2], and the higher the value the more confidence, whilst a TM-score >0.5 indicates a model of accurate topology. When superimposed over the homology model, the I-TASSER prediction had produced an identical structure but with the addition of the missing terminal segments. Given that I-TASSER does not transfer co-factors, prosthetic groups or metal ions, the BLAST homology model was used and the terminal sequences from the I-TASSER results were concatenated. A clear similarity between our complete homology models over the top scoring 4UYL template can be seen in Figure 1.
Figure 1.
The homology models including N- and C-terminus concatenated using I-TASSER structural predictions. Both wild type (A) and L98H mutant (B), in yellow and green, respectively, have been superimposed over the AfCYP51B template structure, blue.
The protein was analyzed for its suitability to span a membrane bilayer. Firstly, the grand average of hydropathy (GRAVY)45 values for the wild type and L98H mutant were −0.216 and −0.230, respectively. Then, using TMHMM,46 we were able to predict the spatial arrangement between the bilayer and the protein (SI Fig. 2). The first six residues at the N-terminal region of wild type and L98H mutant were predicted to be a random coil exposed to the intracellular region of the bilayer, immediately followed by a 23 residue long α-helical integral TM domain. As the sequence is brought back into the bulk of the protein, two coils, similar in length, are expected to interface with the lipid chains, separated by very short extracellular sequences, M39 - F61 and I71 - E91.
Finally, the validity of the predicted TM domain was analyzed further by subjecting the sequence to an experimentally derived free energy of membrane insertion calculation, ΔG predictor.47 The accumulation of individual amino acid contributions (see SI Fig. 3) yielded −0.50 kcal/mol. The non-polar side chains of leucine, isoleucine, valine, and phenylalanine contribute favorably to membrane insertion, while alanine, despite being a non-polar residue, incurs a slight penalty. Asparagine incurs the greatest free energy penalty, however, statistically, asparagine is often found within the center of a TM domain α- helix.47 Taking into account the contribution from the hydrophobic moment, +0.56 kcal/mol, and the contribution for the helix length, −1.20 kcal/mol, the total propensity for insertion was a favorable −1.14 kcal/mol.
Once the TM domain was spanning the POPC lipid bilayer and both systems had been fully solvated, a series of equilibrium steps were performed. The heme prosthetic group and metal iron were restrained as described, and 1,000 kJ/mol position restraints were applied over the protein heavy backbone atoms. The system was subjected to a 10 ps simulation using the NVT ensemble. The restraints were maintained and the Berendsen pressure-coupling was applied to a simulation of 100 ps. Reducing the restraints to 100 kJ/mol the pressure-coupling was replaced with the Nose-Hoover coupling and a further 100 ps was applied. The system continued for a further 100 ps but using a reduced position constraint of 10 kJ/mol.
NPT production runs of 65 ns and 45 ns were performed for the wild type and L98H mutant systems, respectively, from which the root mean square deviation (RMSD) and the area per lipid (APL) were calculated. The RMSD of the initial 40 ns, and 20 ns of the wild type and L98H mutant, respectively, suggest that both systems were still undergoing structural adjustment (SI Fig. 7). It is well understood that computational bilayer systems are prone to long velocity auto-correlation times and therefore require significant equilibration times.48 Visual observation of both systems reveals a stable tertiary structure, with the TM domain consistently spanning the bilayer (Fig. 2A) and the N-terminal exposed to the solvent (Fig. 2B). The secondary structure of the TM domain remained stable (Fig. 2C) and the channel to the buried active site remained accessible to the solvent environment (Fig. 2D).
Figure 2.
Snapshot representative models (taken from the final frame, 45 ns, of the AfCYP51A L98H mutant) of AfCYP51A anchored to a model POPC lipid bilayer. White space-filler spheres represent lipid head group heavy atoms and light blue lines represent alkyl chains. Water molecules have been removed for clarity. (A) The bulk of the protein using van der Waals distances. (B) A depiction of the protein secondary structure. (C) The N-terminus as seen passing through the lipid head group region. (D) The entrances to the active sight (pink helices) nearest to the L98H mutation site (lime green). The heme prosthetic group with bound Fe2+ can be distinguished from the bulk of the protein.
The APL of the model membrane bilayer can be compared to known experimental values to determine whether the bilayer has equilibrated. Frames for lipid analysis from both systems were retained every 5 ns (SI Fig. 4 and SI Fig. 5). After the short initial equilibrium steps, the average APL in both membranes was approximately 76.5 Å2, well beyond the experimentally derived value of 68.3 Å2 for POPC.49 Within the first 5 ns, the APL of both membrane bilayers drops to approximately 67 Å2, and after which the value continually fluctuates within good agreement with the experimental value. In the presence of the TM domain, both sets of boundary lipids (those lipids that immediately interface the protein) show a decrease in APL, indicative of an ordered configuration to the hydrocarbon chains about the α-helical TM domain. The morphology in hydrophobic thickness of the lipid chains is a thoroughly studied consequence of the hydrophobic mismatch between an integral membrane protein and its membrane bilayer.50
Structural analysis of the L98H mutant and a comparison to the wild type was performed using the last 25 ns of each respective production run, from which the coordinates and velocities of each system at 5 ns intervals were obtained for visual inspection. The comparison in Ramachandran plots between the final frame (65 ns) of the wild type sequence with the respective homology model initial structure (SI Fig. 1) yields significant alterations to the dihedral angles of the protein backbone.
The functional group of side chains R451, N125, E104, and the carbonyl group on the backbone of C123, were seen as potential sites for protein-fold interactions with the H98 substitution and native L98. The aliphatic side chain of L98 and the functional ring of H98 were used as a center-of-mass reference for a distance calculation between the aforementioned groups over 25 ns of both trajectories. Nonbonded interatomic interactions, considering the offset from a center-of-mass calculation, can be seen within 0.6 Å (SI Fig. 8). During the 25 ns of the wild-type simulation, N125 and C123 were consistently beyond inter-atomic bonding. This came of little surprise given the hydrophobic mismatch between the functional group of cysteine and asparagine with the aliphatic side chain of leucine. Using the saved velocities and coordinates from the five retrieved time frames (40 ns to 65 ns at 5 ns intervals), 40 ps continuation simulations were recalculated whilst preserving the trajectory. Frames were captured every 0.2 ps. Centroid representations from the short simulations starting from each 5-ns interval time frame have been drawn in Figure 3. The native L98 is consistently beyond the interaction of the N125 carboxamide functional group, which in turn, is shown to interact with the polar complex guanidinium of R451. The native L98 side chain was observed to orientate into the aliphatic region of the side chain of N125. The distance between L98 and E104, although not too great to contribute toward an interatomic interaction would be under a lot of repulsion from the negative charge associated with the α-carboxylic acid group of glutamic acid. A center-of-mass distanced based measurement was performed between the substitution H98 and the functional groups of the nearest side chains R451, N125, E104, and the carbonyl group on the backbone of C123 (SI Fig. 8). As with the wild type, each 5-ns interval performed a 40 ps rerun of the trajectory, while recording frames every 0.2 ps (Fig. 4). The polar complex guanidinium of R451 was shown to sit far within the interaction range of the partially protonated imidazole side chain of histidine, however, given the distance-offset associate with the center-of-mass geometry, it is possibly that there was a brief association toward the latter 10 ns. The functional group of N125 was consistently within a short interaction distance with H98, establishing a hydrogen bond between the imidazole nitrogen bound hydrogen atom to the carbonyl oxygen of the asparagine side chain functional group. An interaction of the L98H mutant with the α-carboxylic acid group of glutamic acid and the carbonyl group on the backbone of the cysteine residues persists while the distance with N125 increases marginally.
Figure 3.
The structural arrangement of the wild type L98 side chain with neighbouring side chains from a centroid frame calculated over the 40 ps simulations. Images A to F correspond to representative structural frames taken over 5 ns intervals from 40 ns to 65 ns. The secondary structure is represented in white ribbons and side chains in thick-coloured atom types.
Figure 4.
The structural arrangement of the mutant H98 side chain with neighbouring side chains from a centroid frame calculated over the 40 ps simulations. Images A to F correspond to representative structural frames taken over 5 ns intervals from 20 ns to 45 ns. The secondary structure is represented in white ribbons and side chains in thick-coloured atom types.
The surface areas occupied on the outside of the catalytic domain of the residues H98, R451, N125, C123, and E104 is reduced as a result of a closer association between the substitution and the neighboring polar side chains. The α-helix, denoted H1 in Figure 5, shifts closer to the channel entrance coil segment, C1, contracting the shorter H3 α-helix. The association between H98 and N125 leads to a short uncoiling of H2 α-helix nearest to the C2 coil.
Figure 5.

A secondary structure representation of AfCYP51A from the final frame of the wild type (blue), and L98H mutant (purple). The α-helices and coils immediately adjacent to the single point mutation have been labeled. The side chains identified from interatomic coordination with the L98H single point mutant have been highlighted in orange, alongside their wild type positions in green.
The adjustments to the secondary structure were considered in relation to the accessible active site surface of the wild type and L98H mutant sequence. The surface area of the active site was calculated for any residue-ligand within 5 Å of the heme prosthetic group and coupled ion. Measurements were taken at 5 ns interval over the final 25 ns of each respective production run. The measurements, collected in Table 1 demonstrate a noticeable decrease in active site surface of the L98H mutant across all recorded instances compared to the wild type.
Table 1.
The active site surface area (Å3) of the wild type and L98H mutant.
| Binding site surface (Å3) | ||||||
|---|---|---|---|---|---|---|
| Wild-type AfCYP51A | 40 ns | 45 ns | 50 ns | 55 ns | 60 ns | 65 ns |
| 1383.6 | 1221.5 | 1305.5 | 1298.3 | 1395.5 | 1430.7 | |
| L98H Mutant AfCYP51A | 20 ns | 25 ns | 30 ns | 35 ns | 40 ns | 45 ns |
| 1075.9 | 1057.4 | 1020.2 | 1087.8 | 1122.6 | 1149.6 | |
Measurements were taken at 5 ns intervals across both final 25 ns trajectories.
Ligand interaction diagrams were generated for each retrieved interval using Maestro 2015-4, highlighting the coordination of Fe2+ with the four pyrrole nitrogen atoms within the heme plane, and the coordination of protein ligand donors to the polar groups of the heme prosthetic group. The contraction of the protein secondary structure after the substitution L98H resulted in a modification to the heme-protein interaction. In the wild type (Fig. 6), Y121 established hydrogen bond coordination between its functional hydroxyl group with carbonyl groups on the heme prosthetic group. Equally, Y107 established a similar coordination over half of the monitored production run, and the backbone amine hydrogen remained attracted to the negative charge of oxygen from the heme prosthetic group. The guanidinium functional group of R369 was shown to hydrogen bond with the oxygen atoms of the heme, during the first 10 ns. This coordination is lost after the final 15 ns. The final coordination is seen between the positively charged functional group of K132 with an oxygen atom of the heme prosthetic group, throughout the recorded wild type production run. These recorded heme-ligand side chain interactions compare well to those observed in the AfCYP51B template crystal structure, notably Y122, Y126, R378, and K14717 (the difference in residue number is due to the offset caused by a difference in primary sequence length).
Figure 6.
Ligand interaction diagrams for the heme binding site of the wild type structure at each 5 ns interval (from A to F) over the final 25 ns trajectory. A line drawn around the heme indicates the binding pocket. Residues ligands are labeled explicitly and shown in stick-form. Non-polar in green, positively charged polar in purple, non-polar neutral (glycine) in yellow, neutral polar in light blue, and negatively charged polar in red.
The reduced active site surface as a result of the L98H substitution yields a set of heme-ligand interaction diagrams (Fig. 7) different to those of the wild type. Neither tyrosines or the arginine, seen during the wild type coordination were present, while in the L98H substitution, G456 was shown to form a hydrogen bond between the backbone amine with a carbonyl oxygen atom of the heme prosthetic group.
Figure 7.
Ligand interaction diagrams for the heme binding site of the L98H mutant structure at each 5 ns interval (from A to F) over the final 25 ns trajectory. A line drawn around the heme indicates the binding pocket. Residues ligands are labeled explicitly and shown in stick-form. Non-polar in green, positively charged polar in purple, non-polar neutral (glycine) in yellow, neutral polar in light blue, and negatively charged polar in red.
Discussion
An earlier study by Liu et al.18 had identified the top 10 homologs, from which the maximum identity scored 50.7%. Since that study, the crystal structures 4UYL and 4UYM of CYP51B from A. fumigatus have been made available, resulting in the additional sequence identity captured in our study.
Based on recent template models, our homology search yielded a structure with an N-terminal helical stretch, unlike earlier homology models. Crystal structures of Saccharomyces cerevisiae CYP51 have identified an α-helical integral membrane anchor segment leading from the N-terminus;25 therefore, we treated this region in our sequence as a TM domain. The accurate representation of the interactions between a lipid bilayer and an integral membrane protein, whether as an anchor to a bilayer or as an extensive membrane channel, is best modelled using explicit lipid representation. Established studies using implicit bilayers were able to account for the hydrophobic mismatch between TM domains and the system solvent,43 however, due to membrane deformation from lipid-protein rearrangement, the tight coupling between protein structure and protein function can only be represented by explicit lipid bodies.44
At closer examination between species, the CYP51 differs in primary sequence length. Further, the TM domain predictions over the AfCYP51A sequence did not yield a TM domain delimited by an intracellular followed by an extracellular region. In addition, during the production MD simulations of wild type and L98H mutant, the suggested TM domain remained helical and continued to span the bilayer. Compared with earlier homology models18 the inclusion of the integral membrane α-helix spanning an explicit lipid bilayer enables time integration of the structure while circumventing the N-terminal region from uncoiling and interacting with the catalytic domain. Our earlier simulations of AfCYP51A presented solely in water solvent (not presented) demonstrated the immediate uncoiling of the TM domain.
A comparison between the absolute terms of the GRAVY score does not reveal a significant difference in hydropathy between sequences. However, as a pair, both structures are considered hydrophobic. Not only is this a result of the inclusion of the TM domain,25 a structural feature of AfCYP51 not studied before using computational chemistry tools but also due to the number of buried hydrophobic side chains within the globular extracellular domain.
After careful equilibration, the early structural deviations from the starting conformation are an initial indication that a homology model falls short of reporting an accurate representation of AfCYP51A. Production run analysis revealed that unlike in the case of the wild type, the L98H mutant can contribute to the stability of the neighboring structure by forming hydrogen-bond interactions with water molecules, instigating bridging interactions between water molecules and close polar side chains (N125, C123, E104, and R451). The L98H substitution, far from the active site, clearly demonstrates a modification to the structural configuration of the neighboring residues. From a visual inspection of the secondary structure arrangement, a change in side chain hydrophobicity, from nonpolar to polar-charged, resulted in a contraction of the protein. This suggests a looser structural configuration in the wild type compared with the mutant, supporting the idea that azole-drug binding is reduced by the mutation.
Not only has the L98H amino acid substitution resulted in a contraction to the secondary structure leading to a reduced active site surface but also the protein coordination with the heme prosthetic group has changed significantly. It is within reason to suggest that these conformation changes may affect the nucleophilic nitrogen of the azole heterocyclic from acting as the sixth coordinating ligand with the heme ferric iron.51 A similar study in 2011 by Snelders et al.20, demonstrated a structural contraction to the active binding cavity and a deviation in ligand donors to the heme prosthetic group. Interestingly, the heme-ligands identified were different to those present in this study. Furthermore, the earlier study used a human template with a sequence identity of only 38%.
Abdolrasouli et al. reported a minimal inhibitory concentration (MIC) of at least 16 mg/L for A. fumigatus isolates harboring the L98H mutation, compared with MIC values in the range 0.25–1 mg/l in wild type isolates.52 We hypothesize that the minimal change in secondary structure as a result of the L98H substitution disrupts the underlying energetics by imposing a significant free energy penalty to itraconazole binding, while leaving the binding of lanosterol unaffected. However, without revealing free energy reaction pathways of triazole-drug binding, a quantitative measure of how these structural changes affect the binding of drug-to-heme remains beyond this study. The results revealed by our simulations, suggest a qualitative insight into resistance of triazole-drugs within the context of the immediate environment and provide a direction of future work and the models necessary to capture drug pathway mechanisms.
Supplementary material
Supplementary data are available at MMYCOL online.
Acknowledgements
The authors wish to acknowledge the valuable input from Dr. Ana Pabis and Dr. Lynn Kamerlin (Uppsala University). We also wish to acknowledge financial contributions via crowd funding, which made this work possible: Mrs. Lynda Parnell, Mr. James Drinkwater, Mrs. Rachel Drinkwater, Mr. Roland Parkes, Mrs. Jane Parkes, Dr. Julia Halder, Ms. Sarah Vermeulen, Dr. Winnie Wu, Dr. Vince Hall, Mrs. Chandni Rosser, Mr. Ian Wright, Mrs. Jane Shorey, Mrs. Karen Leroy, Mr. Robert Huckle, and Mrs. Joanna Huckle.
Author contributions
A. N. and J. R. conceived and designed the experiments. A. N. performed the experiments. Both authors contributed to the writing of the manuscript.
Declaration of interest
The authors report no conflicts of interest. The authors alone are responsible for the content and the writing of the paper.
References
- 1. Walsh TJ, Anaissie EJ, Denning DW et al. Treatment of aspergillosis: clinical practice guidelines of the infectious diseases society of America. Clin Infect Dis. 2008; 46: 327–360. [DOI] [PubMed] [Google Scholar]
- 2. Vermeulen E, Maertens J, De Bel A et al. Nationwide surveillance of azole resistance in Aspergillus disease. Antimicrob Agents Chemother. 2015; 59: 4569–4576. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Chowdhary A, Sharma C, Boom M et al. Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania. J Antimicrob Chemother. 2014; 69: 2979–2983. [DOI] [PubMed] [Google Scholar]
- 4. Vermeulen E, Lagrou K, Verweij PE. Azole resistance in Aspergillus fumigatus: a growing public health concern. Curr Opin Infect Dis. 2013; 26: 493–500. [DOI] [PubMed] [Google Scholar]
- 5. Badali H, Vaezi A, Haghani I et al. Environmental study of azole-resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran. Mycoses. 2013; 56: 659–663. [DOI] [PubMed] [Google Scholar]
- 6. Wiederhold NP, Gil VG, Gutierrez F et al. First detection of TR34 L98H and TR46 Y121F T289A Cyp51 mutations in Aspergillus fumigatus isolates in the United States. J Clin Microbiol. 2016; 54: 168–171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Leonardelli F, Theill L, Nardin ME et al. First itraconazole resistant Aspergillus fumigatus clinical isolate harbouring a G54E substitution in Cyp51A in South America. Rev Iberoam Micol. 2017; 34: 46–48. [DOI] [PubMed] [Google Scholar]
- 8. Chowdhary A, Kathuria S, Xu J et al. Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog. 2013; 9: e1003633. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Meis JF, Chowdhary A, Rhodes JL et al. Clinical implications of globally emerging azole resistance in Aspergillus fumigatus. Phil Trans R Soc B. 2016; 371: 20150460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Mellado E, Garcia-Effron G, Alcazar-Fuoli L et al. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicro Agents Chemother. 2007; 51: 1897–1904. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Abdolrasouli A, Rhodes J, Beale MA et al. Genomic context of azole resistance mutations in Aspergillus fumigatus determined using whole-genome sequencing. MBio. 2015; 6: e00536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Alcazar-Fuoli L, Mellado E. Ergosterol biosynthesis in Aspergillus fumigatus: its relevance as an antifungal target and role in antifungal drug resistance. Front Microbiol. 2013; 3: 1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Chowdhary A, Sharma C, Hagen F et al. Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms. Future Microbiol. 2014; 9: 697–711. [DOI] [PubMed] [Google Scholar]
- 14. Chowdhary A, Kathuria S, Randhawa HS et al. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India. J Antimicrob Chemother. 2011; 67: 362–366. [DOI] [PubMed] [Google Scholar]
- 15. Alcazar-Fuoli L, Cuesta I, Rodriguez-Tudela JL et al. Three-dimensional models of 14α-sterol demethylase (Cyp51A) from Aspergillus lentulus and Aspergillus fumigatus: an insight into differences in voriconazole interaction. Int J Antimicrob Agents. 2011; 38: 426–434. [DOI] [PubMed] [Google Scholar]
- 16. Podust LM, Poulos TL, Waterman MR. Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc Natl Acad Sci U S A. 2001; 98: 3068–3073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Podust LM, Stojan J, Poulos TL et al. Substrate recognition sites in 14α-sterol demethylase from comparative analysis of amino acid sequences and X-ray structure of Mycobacterium tuberculosis CYP51. J Inorg Biochem. 2001; 87: 227–235. [DOI] [PubMed] [Google Scholar]
- 18. Liu M, Zheng N, Li D et al. cyp51A-based mechanism of azole resistance in Aspergillus fumigatus: illustration by a new 3D structural model of Aspergillus fumigatus CYP51A protein. Med Mycol. 2016: 54: 400–408. [DOI] [PubMed] [Google Scholar]
- 19. Xiao L, Madison V, Chau AS et al. Three-dimensional models of wild-type and mutated forms of cytochrome P450 14α-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding. Antimicrob Agents Chemother. 2004; 48: 568–574. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Snelders E, Karawajczyk A, Verhoeven RJ et al. The structure-function relationship of the Aspergillus fumigatus cyp51A L98H conversion by site-directed mutagenesis: the mechanism of L98H azole resistance. Fungal Genet Biol. 2011; 48: 1062–1070. [DOI] [PubMed] [Google Scholar]
- 21. Hargrove TY, Wawrzak Z, Lamb DC et al. Structure-functional characterization of cytochrome P450 sterol 14α-demethylase (CYP51B) from Aspergillus fumigatus and molecular basis for the development of antifungal drugs. J Biol Chem. 2015; 290: 23916–23934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Goncalves SS, Souza ACR, Chowdhary A et al. Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus. Mycoses. 2016; 59: 198–219. [DOI] [PubMed] [Google Scholar]
- 23. Mellado E, Garcia-Effron G, Buitrago MJ et al. Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility. Antimicrob Agents Chemother. 2005; 49: 2536–2538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Hu W, Sillaots S, Lemieux S et al. Essential gene identification and drug target prioritization in Aspergillus fumigatus. PLoS Pathogens. 2007; 3: e24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Monk BC, Tomasiak TM, Keniya MV et al. Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer. Proc Natl Acad Sci U S A. 2014; 111: 3865–3870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Dal Peraro M, Spiegel K, Lamoureux G et al. Modeling the charge distribution at metal sites in proteins for molecular dynamics simulations. J Struct Biol. 2007; 157: 444–453. [DOI] [PubMed] [Google Scholar]
- 27. Duarte F, Bauer P, Barrozo A et al. Force field independent metal parameters using a nonbonded dummy model. J Phys Chem B. 2014; 118: 4351–4362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Mellado E, Garcia-Effron G, Alcazar-Fuoli L et al. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother. 2007; 51: 1897–1904. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Liu M, Zeng R, Zhang L et al. Multiple cyp51A-based mechanisms identified in azole-resistant isolates of Aspergillus fumigatus from China. Antimicrob Agents Chemother. 2015; 59: 4321–4325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Abraham MJ, Murtola T, Schulz R et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015; 1: 19–25. [Google Scholar]
- 31. Hess B, Bekker H, Berendsen HJC et al. LINCS: a linear constraint solver for molecular simulations. J Comput Chem. 1997; 18: 1463–1472. [Google Scholar]
- 32. Darden T, York D, Pedersen L. Particle mesh Ewald: an N log (N) method for Ewald sums in large systems. J Chem Phys. 1993; 98: 10089–10092. [Google Scholar]
- 33. Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J Chem Phys. 2007; 126: 014101. [DOI] [PubMed] [Google Scholar]
- 34. Berendsen HJC, Postma JPM, van Gunsteren WF et al. Molecular dynamics with coupling to an external bath. J Chem Phys. 1984; 81: 3684–3690. [Google Scholar]
- 35. Parrinello M, Rahman A. Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys. 1981; 52: 7182–7190. [Google Scholar]
- 36. Berger O, Edholm O, Jähnig F. Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature. Biophys J. 1997; 72: 2002–2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Cordomí A, Caltabiano G, Pardo L. Membrane protein simulations using AMBER force field and Berger lipid parameters. J Chem Theory Comput. 2012; 8: 948–958. [DOI] [PubMed] [Google Scholar]
- 38. Shahrokh K, Orendt A, Yost GS et al. Quantum mechanically derived AMBER-compatible heme parameters for various states of the cytochrome P450 catalytic cycle. J Comput Chem. 2012; 33:119–133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Liao Q, Kamerlin SCL, Strodel B. Development and application of a nonbonded Cu2+ model that includes the Jahn–Teller effect. J Phys Chem Lett. 2015; 6: 2657–2662. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Larkin MA, Blackshields G, Brown NP et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007; 23: 2947–2948. [DOI] [PubMed] [Google Scholar]
- 41. Jacobson MP, Pincus DL, Rapp CS et al. A hierarchical approach to all-atom protein loop prediction. Proteins. 2004; 55: 351–367. [DOI] [PubMed] [Google Scholar]
- 42. Yang J, Zhang W, He B et al. Template-based protein structure prediction in CASP11 and retrospect of I-TASSER in the last decade. Proteins. 2015; 81 (Suppl 1): 233–246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Im W, Feig M, Brooks CL. An implicit membrane generalized born theory for the study of structure, stability, and interactions of membrane proteins. Biophys J. 2003; 85: 2900–2918. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Lundbæk JA, Collingwood SA, Ingólfsson HI et al. Lipid bilayer regulation of membrane protein function: gramicidin channels as molecular force probes. J R Soc Interface. 2010; 7:373–395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982; 157: 105–132. [DOI] [PubMed] [Google Scholar]
- 46. Krogh A, Larsson B, Von Heijne G et al. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol. 2001; 305: 567–580. [DOI] [PubMed] [Google Scholar]
- 47. Hessa T, Meindl-Beinker NM, Bernsel A et al. Molecular code for transmembrane-helix recognition by the Sec61 translocon. Nature. 2007; 450: 1026–1030. [DOI] [PubMed] [Google Scholar]
- 48. Porasso RD, Cascales JJL. A criterion to identify the equilibration time in lipid bilayer simulations. Papers in Physics. 2012; 4: 040005. [Google Scholar]
- 49. Kučerka N, Tristram-Nagle S, Nagle JF. Structure of fully hydrated fluid phase lipid bilayers with monounsaturated chains. J Membr Biol. 2006; 208: 193–202. [DOI] [PubMed] [Google Scholar]
- 50. Kahraman O, Koch PD, Klug WS et al. Bilayer-thickness- mediated interactions between integral membrane proteins. Phys Rev E. 2016; 93: 042410. [DOI] [PubMed] [Google Scholar]
- 51. Jefcoate CR, Gaylor JL, Calabrese R. Ligand interactions with cytochrome P-450. I. binding of primary amines. Biochemistry. 1969; 8: 3455–3463. [DOI] [PubMed] [Google Scholar]
- 52. Abdolrasouli A, Rhodes J, Beale MA et al. Genomic context of azole resistance mutations in Aspergillus fumigatus determined using while-genome sequences. MBio. 2015; 6: e00536–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.






